Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5041733 | 5913916 | F | 2 | 5041733-6 | 20050927 | 20060616 | 20060630 | EXP | HQWYE056017OCT05 | WYETH PHARMACEUTICALS INC. | 77 | YR | F | N | 59.3 | KG | 20060628 | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5041733 | 1007435642 | PS | MYLOTARG | 1 | INTRAVENOUS | 10 MG 1X PER 1 DAY, INTRAVENOUS | D | D | 21174 | ||
| 5041733 | 1007457403 | C | CYTARABINE | 1 | |||||||
| 5041733 | 1007457407 | C | NOVANTRONE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5041733 | 1007435642 | ACUTE MYELOID LEUKAEMIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5041733 | HO |
| 5041733 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5041733 | CHILLS |
| 5041733 | FEBRILE NEUTROPENIA |
| 5041733 | WHITE BLOOD CELL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5041733 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5041733 | 1007435642 | 20050909 | 20050909 |